title: Human MLH1 protein participates in genomic damage checkpoint signaling in response to DNA interstrand crosslinks, while MSH2 functions in DNA repair.
abstract: DNA interstrand crosslinks (ICLs) are among the most toxic types of damage to a cell. For this reason, many ICL-inducing agents are effective therapeutic agents. For example, cisplatin and nitrogen mustards are used for treating cancer and psoralen plus UVA (PUVA) is useful for treating psoriasis. However, repair mechanisms for ICLs in the human genome are not clearly defined. Previously, we have shown that MSH2, the common subunit of the human MutSalpha and MutSbeta mismatch recognition complexes, plays a role in the error-free repair of psoralen ICLs. We hypothesized that MLH1, the common subunit of human MutL complexes, is also involved in the cellular response to psoralen ICLs. Surprisingly, we instead found that MLH1-deficient human cells are more resistant to psoralen ICLs, in contrast to the sensitivity to these lesions displayed by MSH2-deficient cells. Apoptosis was not as efficiently induced by psoralen ICLs in MLH1-deficient cells as in MLH1-proficient cells as determined by caspase-3/7 activity and binding of annexin V. Strikingly, CHK2 phosphorylation was undetectable in MLH1-deficient cells, and phosphorylation of CHK1 was reduced after PUVA treatment, indicating that MLH1 is involved in signaling psoralen ICL-induced checkpoint activation. Psoralen ICLs can result in mutations near the crosslinked sites; however, MLH1 function was not required for the mutagenic repair of these lesions, and so its signaling function appears to have a role in maintaining genomic stability following exposure to ICL-induced DNA damage. Distinguishing the genetic status of MMR-deficient tumors as MSH2-deficient or MLH1-deficient is thus potentially important in predicting the efficacy of treatment with psoralen and perhaps with other ICL-inducing agents.
authors.affiliation: Department of Carcinogenesis, University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas, United States of America.
authors.forename: Qi
authors.initials: Q
authors.lastname: Wu
authors.forename: Karen M
authors.initials: KM
authors.lastname: Vasquez
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D003432:Cross-Linking Reagents / Q000633:toxicity; D004247:DNA / Q000378:metabolism; D004249:DNA Damage; D004260:DNA Repair / Q000502:physiology*; D005363:Ficusin / Q000633:toxicity; D018816:Genes, cdc / Q000502:physiology; D015894:Genome, Human; D006801:Humans; D000070957:MutL Protein Homolog 1; D051718:MutS Homolog 2 Protein / Q000378:metabolism*; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000235:genetics
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D003432:Cross-Linking Reagents; C501486:MLH1 protein, human; D009687:Nuclear Proteins; D004247:DNA; C497172:MSH2 protein, human; D000070957:MutL Protein Homolog 1; D051718:MutS Homolog 2 Protein; D005363:Ficusin
references.citation: J Biol Chem. 2006 Oct 13;281(41):30305-9
references.pmid: 16905530
references.citation: Gastroenterology. 2005 Aug;129(2):537-49
references.pmid: 16083711
references.citation: Mutat Res. 1983 Dec;124(3-4):287-97
references.pmid: 6656829
references.citation: DNA Repair (Amst). 2005 Aug 15;4(9):983-93
references.pmid: 15996534
references.citation: Carcinogenesis. 1999 May;20(5):799-804
references.pmid: 10334196
references.citation: Natl Cancer Inst Monogr. 1984 Dec;66:127-36
references.pmid: 6397690
references.citation: Nucleic Acids Res. 1999 Feb 15;27(4):1176-81
references.pmid: 9927753
references.citation: Carcinogenesis. 1996 Sep;17(9):2085-8
references.pmid: 8824540
references.citation: Clin Cancer Res. 1997 Oct;3(10):1763-7
references.pmid: 9815561
references.citation: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):5848-53
references.pmid: 11972036
references.citation: Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6443-7
references.pmid: 8692834
references.citation: Genes Dev. 2004 Jun 1;18(11):1331-44
references.pmid: 15175264
references.citation: Cancer Res. 1996 Nov 1;56(21):4881-6
references.pmid: 8895738
references.citation: Nucleic Acids Res. 2005 May 24;33(9):2993-3001
references.pmid: 15914671
references.citation: Cancer Res. 1995 Sep 1;55(17):3721-5
references.pmid: 7641183
references.citation: Oncogene. 2003 Sep 18;22(40):6119-28
references.pmid: 13679850
references.citation: Lancet Oncol. 2001 Aug;2(8):483-90
references.pmid: 11905724
references.citation: Mol Biol Cell. 2005 Mar;16(3):1513-26
references.pmid: 15647386
references.citation: Mol Cell. 1999 Sep;4(3):439-44
references.pmid: 10518225
references.citation: Q Rev Biophys. 2002 Feb;35(1):89-107
references.pmid: 11997982
references.citation: Carcinogenesis. 2001 Dec;22(12):1931-7
references.pmid: 11751422
references.citation: Nat Genet. 2003 Jan;33(1):80-4
references.pmid: 12447371
references.citation: Mol Cell Biol. 2002 Apr;22(7):2388-97
references.pmid: 11884621
references.citation: Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10764-9
references.pmid: 10485900
references.citation: J Biol Chem. 2001 Aug 24;276(34):31551-60
references.pmid: 11390398
references.citation: Mol Cell Biol. 2001 Feb;21(3):713-20
references.pmid: 11154259
references.citation: Eur J Biochem. 1996 Jun 1;238(2):297-307
references.pmid: 8681938
references.citation: EMBO Rep. 2005 Jun;6(6):551-7
references.pmid: 15891767
references.citation: Science. 1998 Dec 4;282(5395):1893-7
references.pmid: 9836640
references.citation: Carcinogenesis. 1999 Dec;20(12):2317-26
references.pmid: 10590226
references.citation: Cancer Res. 1997 Sep 1;57(17):3784-91
references.pmid: 9288788
references.citation: Biochem Pharmacol. 1992 Mar 3;43(5):1159-63
references.pmid: 1532492
references.citation: Annu Rev Biochem. 1996;65:101-33
references.pmid: 8811176
references.citation: Dermatol Clin. 1998 Apr;16(2):227-34
references.pmid: 9589196
references.citation: Biochem Biophys Res Commun. 2004 May 21;318(1):297-302
references.pmid: 15110787
references.citation: Biochemistry. 1996 Aug 20;35(33):10712-9
references.pmid: 8718860
references.citation: Nucleic Acids Res. 1997 Feb 1;25(3):491-6
references.pmid: 9016586
references.citation: EMBO J. 2003 May 1;22(9):2245-54
references.pmid: 12727890
references.citation: Mol Cell. 2006 May 19;22(4):501-10
references.pmid: 16713580
references.citation: J Biol Chem. 1999 Jun 11;274(24):16894-900
references.pmid: 10358035
references.citation: Nat Rev Mol Cell Biol. 2006 May;7(5):335-46
references.pmid: 16612326
references.citation: Chem Rev. 2006 Feb;106(2):302-23
references.pmid: 16464007
references.citation: J Biol Chem. 2003 Jun 6;278(23):21267-75
references.pmid: 12654906
references.citation: Cancer Res. 1997 Nov 15;57(22):5143-7
references.pmid: 9371516
references.citation: Mol Cell Biol. 2000 Nov;20(21):8283-9
references.pmid: 11027296
references.citation: EMBO J. 2004 Mar 10;23(5):1178-87
references.pmid: 14988723
references.citation: J Biol Chem. 2002 Mar 8;277(10):8260-6
references.pmid: 11756455
references.citation: Mol Carcinog. 2004 Jun;40(2):122-33
references.pmid: 15170817
references.citation: Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5602-6
references.pmid: 2062839
references.citation: Mol Cell Biol. 1999 Dec;19(12):8292-301
references.pmid: 10567554
references.citation: Annu Rev Biochem. 2004;73:39-85
references.pmid: 15189136
references.citation: Biochemistry. 2005 Mar 22;44(11):4188-95
references.pmid: 15766246
references.citation: Mutat Res. 1989 May;217(3):193-201
references.pmid: 2541332